Global Guaifenesin (API) Market Professional Survey Report 2018 - 2025

Description

This report studies the global Guaifenesin (API) market status and forecast, categorizes the global Guaifenesin (API) market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
The global average price of Guaifenesin (API) is in the decreasing trend, from 8.62 USD/Kg in 2012 to 7.61 USD/Kg in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Guaifenesin (API) includes 98%-99% Guaifenesin and >99% Guaifenesin, and the proportion of >99% Guaifenesin is about 74%, and the proportion is in increasing trend from 2012 to 2016.
Guaifenesin (API) is mainly used in Pharmaceuticals industry. The proportion of Guaifenesin (API) used in Pharmaceuticals industry is about 92%.
The global Guaifenesin (API) market is valued at 56 million US$ in 2017 and will reach 58 million US$ by the end of 2025, growing at a CAGR of 0.5% during 2018-2025.

The major manufacturers covered in this report
Granules
Synthokem Labs
Haizhou Pharma
Yuan Cheng Group
Stellar Chemical
Biesterfeld
Seven Star Pharma
Camlin Fine Science
Gennex Lab
Iwaki Seiyaku
Pan Drugs
Delta Synthetic
Smart Pharm

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
India
Southeast Asia
Other regions (Central & South America, Middle East & Africa)

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
98%-99%
>99%

By Application, the market can be split into
Pharmaceuticals
Others

The study objectives of this report are:
To analyze and study the global Guaifenesin (API) capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Guaifenesin (API) manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Guaifenesin (API) are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Guaifenesin (API) Manufacturers
Guaifenesin (API) Distributors/Traders/Wholesalers
Guaifenesin (API) Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, We offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Guaifenesin (API) market, by end-use.
Detailed analysis and profiles of additional market players.

TABLE OF CONTENT

Table of Contents

Global Guaifenesin (API) Market Professional Survey Report 2018
1 Industry Overview of Guaifenesin (API)
1.1 Definition and Specifications of Guaifenesin (API)
1.1.1 Definition of Guaifenesin (API)
1.1.2 Specifications of Guaifenesin (API)
1.2 Classification of Guaifenesin (API)
1.2.1 98%-99%
1.2.2 >99%
1.3 Applications of Guaifenesin (API)
1.3.1 Pharmaceuticals
1.3.2 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India

2 Manufacturing Cost Structure Analysis of Guaifenesin (API)
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Guaifenesin (API)
2.3 Manufacturing Process Analysis of Guaifenesin (API)
2.4 Industry Chain Structure of Guaifenesin (API)

3 Technical Data and Manufacturing Plants Analysis of Guaifenesin (API)
3.1 Capacity and Commercial Production Date of Global Guaifenesin (API) Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Guaifenesin (API) Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Guaifenesin (API) Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Guaifenesin (API) Major Manufacturers in 2017

4 Global Guaifenesin (API) Overall Market Overview
4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2013-2018E Global Guaifenesin (API) Capacity and Growth Rate Analysis
4.2.2 2017 Guaifenesin (API) Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2013-2018E Global Guaifenesin (API) Sales and Growth Rate Analysis
4.3.2 2017 Guaifenesin (API) Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2013-2018E Global Guaifenesin (API) Sales Price
4.4.2 2017 Guaifenesin (API) Sales Price Analysis (Company Segment)

5 Guaifenesin (API) Regional Market Analysis
5.1 North America Guaifenesin (API) Market Analysis
5.1.1 North America Guaifenesin (API) Market Overview
5.1.2 North America 2013-2018E Guaifenesin (API) Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2013-2018E Guaifenesin (API) Sales Price Analysis
5.1.4 North America 2017 Guaifenesin (API) Market Share Analysis
5.2 Europe Guaifenesin (API) Market Analysis
5.2.1 Europe Guaifenesin (API) Market Overview
5.2.2 Europe 2013-2018E Guaifenesin (API) Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2013-2018E Guaifenesin (API) Sales Price Analysis
5.2.4 Europe 2017 Guaifenesin (API) Market Share Analysis
5.3 China Guaifenesin (API) Market Analysis
5.3.1 China Guaifenesin (API) Market Overview
5.3.2 China 2013-2018E Guaifenesin (API) Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China 2013-2018E Guaifenesin (API) Sales Price Analysis
5.3.4 China 2017 Guaifenesin (API) Market Share Analysis
5.4 Japan Guaifenesin (API) Market Analysis
5.4.1 Japan Guaifenesin (API) Market Overview
5.4.2 Japan 2013-2018E Guaifenesin (API) Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan 2013-2018E Guaifenesin (API) Sales Price Analysis
5.4.4 Japan 2017 Guaifenesin (API) Market Share Analysis
5.5 Southeast Asia Guaifenesin (API) Market Analysis
5.5.1 Southeast Asia Guaifenesin (API) Market Overview
5.5.2 Southeast Asia 2013-2018E Guaifenesin (API) Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2013-2018E Guaifenesin (API) Sales Price Analysis
5.5.4 Southeast Asia 2017 Guaifenesin (API) Market Share Analysis
5.6 India Guaifenesin (API) Market Analysis
5.6.1 India Guaifenesin (API) Market Overview
5.6.2 India 2013-2018E Guaifenesin (API) Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2013-2018E Guaifenesin (API) Sales Price Analysis
5.6.4 India 2017 Guaifenesin (API) Market Share Analysis

6 Global 2013-2018E Guaifenesin (API) Segment Market Analysis (by Type)
6.1 Global 2013-2018E Guaifenesin (API) Sales by Type
6.2 Different Types of Guaifenesin (API) Product Interview Price Analysis
6.3 Different Types of Guaifenesin (API) Product Driving Factors Analysis
6.3.1 98%-99% Growth Driving Factor Analysis
6.3.2 >99% Growth Driving Factor Analysis

7 Global 2013-2018E Guaifenesin (API) Segment Market Analysis (by Application)
7.1 Global 2013-2018E Guaifenesin (API) Consumption by Application
7.2 Different Application of Guaifenesin (API) Product Interview Price Analysis
7.3 Different Application of Guaifenesin (API) Product Driving Factors Analysis
7.3.1 Pharmaceuticals of Guaifenesin (API) Growth Driving Factor Analysis
7.3.2 Others of Guaifenesin (API) Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Guaifenesin (API)
8.1 Granules
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Granules 2017 Guaifenesin (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Granules 2017 Guaifenesin (API) Business Region Distribution Analysis
8.2 Synthokem Labs
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Synthokem Labs 2017 Guaifenesin (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Synthokem Labs 2017 Guaifenesin (API) Business Region Distribution Analysis
8.3 Haizhou Pharma
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Haizhou Pharma 2017 Guaifenesin (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Haizhou Pharma 2017 Guaifenesin (API) Business Region Distribution Analysis
8.4 Yuan Cheng Group
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Yuan Cheng Group 2017 Guaifenesin (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Yuan Cheng Group 2017 Guaifenesin (API) Business Region Distribution Analysis
8.5 Stellar Chemical
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Stellar Chemical 2017 Guaifenesin (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Stellar Chemical 2017 Guaifenesin (API) Business Region Distribution Analysis
8.6 Biesterfeld
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Biesterfeld 2017 Guaifenesin (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Biesterfeld 2017 Guaifenesin (API) Business Region Distribution Analysis
8.7 Seven Star Pharma
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Seven Star Pharma 2017 Guaifenesin (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Seven Star Pharma 2017 Guaifenesin (API) Business Region Distribution Analysis
8.8 Camlin Fine Science
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Camlin Fine Science 2017 Guaifenesin (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Camlin Fine Science 2017 Guaifenesin (API) Business Region Distribution Analysis
8.9 Gennex Lab
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Gennex Lab 2017 Guaifenesin (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Gennex Lab 2017 Guaifenesin (API) Business Region Distribution Analysis
8.10 Iwaki Seiyaku
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Iwaki Seiyaku 2017 Guaifenesin (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Iwaki Seiyaku 2017 Guaifenesin (API) Business Region Distribution Analysis
8.11 Pan Drugs
8.12 Delta Synthetic
8.13 Smart Pharm

9 Development Trend of Analysis of Guaifenesin (API) Market
9.1 Global Guaifenesin (API) Market Trend Analysis
9.1.1 Global 2018-2025 Guaifenesin (API) Market Size (Volume and Value) Forecast
9.1.2 Global 2018-2025 Guaifenesin (API) Sales Price Forecast
9.2 Guaifenesin (API) Regional Market Trend
9.2.1 North America 2018-2025 Guaifenesin (API) Consumption Forecast
9.2.2 Europe 2018-2025 Guaifenesin (API) Consumption Forecast
9.2.3 China 2018-2025 Guaifenesin (API) Consumption Forecast
9.2.4 Japan 2018-2025 Guaifenesin (API) Consumption Forecast
9.2.5 Southeast Asia 2018-2025 Guaifenesin (API) Consumption Forecast
9.2.6 India 2018-2025 Guaifenesin (API) Consumption Forecast
9.3 Guaifenesin (API) Market Trend (Product Type)
9.4 Guaifenesin (API) Market Trend (Application)

10 Guaifenesin (API) Marketing Type Analysis
10.1 Guaifenesin (API) Regional Marketing Type Analysis
10.2 Guaifenesin (API) International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Guaifenesin (API) by Region
10.4 Guaifenesin (API) Supply Chain Analysis

11 Consumers Analysis of Guaifenesin (API)
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 Conclusion of the Global Guaifenesin (API) Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source

Choose License Type

Checkout Inquiry